1. Megarbane, Andre, Bizzari, Sami, Deepthi, Asha, Delague, Valérie, Urtizberea, J Andoni. . A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort. In Journal of neuromuscular diseases, 9, 193-210. doi:10.3233/JND-210652. https://pubmed.ncbi.nlm.nih.gov/34602496/
2. Liu, Fang, Dai, Liying, Li, Zhi, Yin's, Xiaowei. 2023. Novel variants of NEK9 associated with neonatal arthrogryposis: Two case reports and a literature review. In Frontiers in genetics, 13, 989215. doi:10.3389/fgene.2022.989215. https://pubmed.ncbi.nlm.nih.gov/36712877/
3. Jung, Richard, Radko, Sandi, Pelka, Peter. 2015. The Dual Nature of Nek9 in Adenovirus Replication. In Journal of virology, 90, 1931-43. doi:10.1128/JVI.02392-15. https://pubmed.ncbi.nlm.nih.gov/26676776/
4. Kurioka, Daisuke, Takeshita, Fumitaka, Tsuta, Koji, Kohno, Takashi, Tsuchiya, Naoto. 2014. NEK9-dependent proliferation of cancer cells lacking functional p53. In Scientific reports, 4, 6111. doi:10.1038/srep06111. https://pubmed.ncbi.nlm.nih.gov/25131192/
5. Lu, Guofang, Tian, Siyuan, Sun, Yi, Feng, Bin, Shang, Yulong. 2021. NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation. In Theranostics, 11, 2460-2474. doi:10.7150/thno.53169. https://pubmed.ncbi.nlm.nih.gov/33500736/
6. Smith, Scott C, Petrova, Aleksandra V, Madden, Matthew Z, Wang, Ya, Yu, David S. 2014. A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response. In Nucleic acids research, 42, 11517-27. doi:10.1093/nar/gku840. https://pubmed.ncbi.nlm.nih.gov/25217585/
7. Casey, Jillian P, Brennan, Kieran, Scheidel, Noemie, Murphy, Helen, Lynch, Sally Ann. 2016. Recessive NEK9 mutation causes a lethal skeletal dysplasia with evidence of cell cycle and ciliary defects. In Human molecular genetics, 25, 1824-35. doi:10.1093/hmg/ddw054. https://pubmed.ncbi.nlm.nih.gov/26908619/
智鼠故事 
